1. Home
  2. EVTL vs IMUX Comparison

EVTL vs IMUX Comparison

Compare EVTL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$5.69

Market Cap

542.9M

Sector

Industrials

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.62

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
IMUX
Founded
2016
2016
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.9M
85.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVTL
IMUX
Price
$5.69
$0.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$13.20
$6.00
AVG Volume (30 Days)
2.5M
1.2M
Earning Date
08-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.56
52 Week High
$15.99
$1.39

Technical Indicators

Market Signals
Indicator
EVTL
IMUX
Relative Strength Index (RSI) 54.89 36.87
Support Level $5.60 $0.66
Resistance Level $6.19 $0.70
Average True Range (ATR) 0.59 0.04
MACD 0.07 -0.00
Stochastic Oscillator 48.92 25.81

Price Performance

Historical Comparison
EVTL
IMUX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: